Motivational Interviewing: Participant Characteristics and Early Retention in Community Clinics Samuel A. Ball Kathleen M. Carroll Training Director Principal.

Slides:



Advertisements
Similar presentations
13 Principles of Effective Addictions Treatment
Advertisements

Ensuring Quality Services and the Protection of Patients’ Welfare A GPS for quality care. Jeanne L. Obert Executive Director Matrix Institute on Addictions.
Predictors of Change in HIV Risk Factors for Adolescents Admitted to Substance Abuse Treatment Passetti, L. L., Garner, B. R., Funk, R., Godley, S. H.,
What is the evidence for time limiting addiction treatment?
Background: The low retention rates among African Americans in substance abuse treatment (Milligan et al., 2004) combined with the limited number of treatments.
Site Dev Highlighted article or topic – Transport Findings Update and Summary _____________________________________ Website: Pre Sonja Schoenwald, Ph.D.
Social identification and support within the Therapeutic Community Genevieve Dingle & Cassandra Perryman School of Psychology The.
Effectiveness of two-stage training for brief interventionists in a multi-site trial Michael P. Bogenschutz, 1 Alyssa A. Forcehimes, 1 Christine Sanchez,
Motivational Interviewing to Improve Treatment Engagement and Outcome* The effect of one session on retention Research findings from the NIDA Clinical.
Motivational Interviewing in the Primary Care Setting Presented by: Jonathan Betlinski, MD Date: 02/26/2015.
Teaching medical students in early interventions in “New chances for early interventions in the general practice” Jean-Bernard Daeppen, Lausanne, Switzerland.
Early Childhood Mental Health Consultants Early Childhood Consultation Partnership® Funded and Supported by Connecticut’s Department of Children and Families.
A. FORCEHIMES K. WILSON T. MOYERS J. TILLMAN C. DUNN C. LIZARRAGA C. RIPP Intervention Training, Supervision and Fidelity Monitoring in NIDA CTN 0047:
Participant Choice – Access to Recovery as a Voucher Service Delivery Model Presented to National Summit on Prisoner Re-Entry Sponsored by the White House.
Introduction There is a growing body of literature supporting the 12- step approach for stimulant users (see Donovan & Wells 1 for a review). Important.
SUBSTANCE USE DISORDERS GENERAL METHODS OF TREATMENT Inpatient Detoxification and Rehabilitation Outpatient Individual, Couple, or Family Counseling Self-help.
A Meta-Analysis of Research on Motivational Interviewing Treatment Effectiveness (MARMITE) Jennifer Hettema Julie Steele William R. Miller Annual Review.
Elizabeth Eccles, MS, RN.  A primary role of nurse in health care is to help maximize health in patients across their lifespan  For those with chronic.
Attractive Addiction Treatment...? Can we make addiction treatment engaging?
Audrey J. Brooks, PhD University of Arizona CA-AZ node.
Frequency and type of adverse events associated with treating women with trauma in community substance abuse treatment programs T. KIlleen 1, C. Brown.
NIDA/SAMHSA Blending Initiative Overview. Advances in science are giving us a broad range of promising options for treating substance use disorders, BUT.
Evidence-Based Practice: Psychosocial Interventions Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM NIDA Blending Conference June 3, 2008 Cincinnati, Ohio.
The CTN Research Utilization Committee: Putting Dissemination Research into Practice Jeffrey Selzer, MD Chair, CTN Research Utilization Committee Long.
Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.
T HE RELATIONSHIP OF COUNSELOR - LEVEL VARIABLES TO INTERVENTION ADOPTION Joseph Guydish, Holly Fussell, Sarah Turcotte Manser, Lynn E. Kunkel, Mable Chan,
Harold I Perl, PhD Center for the Clinical Trials Network National Institute on Drug Abuse NIATx Summit and SAAS National Conference Boston, MA July 13,
C:\laam\lamAPA.ppt 8/04/98 Heroin Addiction Treatment: A Comparison of Methadone and LAAM M. Douglas Anglin, Ph.D. Douglas Longshore, Ph.D. Jeffrey J.
Principles of Drug Addiction Treatment (Section 5 continued…) UCLA Integrated Substance Abuse Programs Continuum of Care 1.
METHODS Sample n=245 Women, 24% White, 72% Average age, 36.5 Never married, 51% Referral Sources (%) 12-Month DSM-IV Substance Dependence Prior to Entering.
Competency of Psychiatry Residents in the Treatment of Severe Mental Illness Before and After a Psychiatric Rehabilitation Community Rotation Melinda Randall.
Mission Statement Client Demographics Presenting Problems Dual Identity Program Goals & Objectives Description of Program Program Accomplishments and.
Implementation of Evidence-Based Models: Improving Processes Jeanne L. Obert, MFT, MSM Executive Director, Matrix Institute UCLA Integrated Substance Abuse.
Therapeutic Alliance and Length of Stay Implementation of Patient Feedback A total of 41 clinicians and 9 supervisors participated in the Patient Feedback.
Evidence-based treatment has become a strong emphasis in the addiction field. From results of trials comparing one treatment to another, we now have many.
Specific Aims  Modify a previously used ACASI (audio computer assisted structured interview) assessment tool, the Sexual Behavior Inventory (SBI), for.
Recovery Support Services and Client Outcomes: What do the Data Tell Us? Recovery Community Services Program Grantee Meeting December 14, 2007.
MIA: STEP Toolkit Overview. NIDA-SAMHSA Blending Initiative 2 What is an MI Assessment?  Use of client-centered MI style  MI strategies that can be.
EMPIRICALLY-SUPPORTED TREATMENTS FOR STIMULANT DEPENDENCE RICHARD A. RAWSON, Ph.D. UCLA INTEGRATED SUBSTANCE ABUSE PROGRAMS (ISAP) October 9, 2004.
Contingency Management Contingency management (CM) refers to the systematic application of basic principles delineated by workers in the field of the Experimental.
Elizabeth WellsDennis Daley School of Social WorkWestern Psychiatric Institute University of WashingtonUniversity of Pittsbu rgh Supported by Grants #
Harold I Perl, PhD National Institute on Drug Abuse APA 120 th Annual Convention August 3, 2012.
Participants were recruited from 6 drug free, psychosocial treatment (PT) and 5 methadone maintenance (MM) programs (N = 628) participating in a NIDA Clinical.
Abstinence Incentives for Methadone Maintained Stimulant Users: Outcomes for Those Testing Stimulant Positive vs Negative at Study Intake Maxine L. Stitzer.
Exploration of the Substance Abuse Treatment Workforce: Education, Preparation and Certification Traci Rieckmann, Ph.D., Bret Fuller, Ph.D, Dennis McCarty,
Patient and Staff Satisfaction in Outpatient Substance Abuse Treatment Programs A. Kulaga 1, B. McClure 1, J. Rotrosen 1, P. Crits-Christoph 2, S. Ring-Kurtz.
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
EFFICACY OF A STAGE-BASED BEHAVIORAL INTERVENTION TO PROMOTE STI SCREENING IN YOUNG WOMEN: A RANDOMIZED CONTROLLED TRIAL Chacko MR, Wiemann CM, Kozinetz.
Methamphetamine: User Characteristics and Treatment Response Alice Huber, Ph.D. Steven Shoptaw, Ph.D. Richard A. Rawson, Ph.D. Paul Brethen, M.A. Walter.
Abstinence Incentive Effects in Psychosocial Counseling Patients Testing Stimulant Positive vs Negative at Treatment Entry Maxine L. Stitzer Johns Hopkins.
California Addiction Training and Education Series Jeanne L. Obert, MFT, MSM Executive Director, Matrix Institute on Addictions Methamphetamine Behavioral.
Training Community Treatment Providers in Research Interventions for Women with Addictions and PTSD Gloria M. Miele, Ph.D. Training Director, CTN Long.
Relational Discord at Conclusion of Treatment Predicts Future Substance Use for Partnered Patients Wayne H. Denton, MD, PhD; Paul A. Nakonezny, PhD; Bryon.
Adoption of HIV Counseling and Testing Following Completion of Randomized Clinical Trial Louise Haynes 1, Beverly Holmes 2, Anna Amberg 2, Kathleen Brady.
Introduction Results and Conclusions On counselor background variables, no differences were found between the MH and SA COSPD specialists on race/ethnicity,
1 Clinical Supervision in the CTN: Availability, Content, and Impact on Counselors Lori J. Ducharme, Hannah K. Knudsen, J. Aaron Johnson & Paul M. Roman.
Effectiveness, Quality, Performance : What’s the Difference? & How do you use them?
TREATMENT OF SUBSTANCE USE DISORDERS TX myths 1. Nothing works 2. One approach is superior to all others (“one true light” tradition) 3. All treatment.
Motivational Interviewing in the Primary Care Setting
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
Predictors of study retention in addiction treatment trials KORTE JE 1, MAGRUDER KM 1,2, KILLEEN TK 1, SONNE SC 1, SAMPSON RR 1 and BRADY KT 1,2 1. Medical.
BEHAVIORAL FAMILY COUNSELING AND NALTREXONE FOR MALE OPIOID-DEPENDENT PATIENTS William Fals-Stewart, Ph.D. Research Institute on Addictions.
1 Assessment Guided Life Planning: The San Diego SB 618 Prisoner Reentry Experience Criminal Justice Research Division Darlanne Hoctor Mulmat
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Predictors of study retention in drug abuse treatment trials
Implementing evidence-based psychosocial therapies for substance use: Aspects of measuring adherence and competence Andrea Meier, Mark P. McGovern, Bethany.
Levels of Care Continuum of Care ASAM Patient Placement Criteria (PPC)
Using Observation to Enhance Supervision CIMH Symposium Supervisor Track Oakland, California April 27, 2012.
Can Primary Care Physicians Learn and Adopt Brief Motivational Interviewing Techniques in their Practice? Alan Adelman, MD, MS David Richard, MD Robert.
Treatment for PTSD and SUD:
Presentation transcript:

Motivational Interviewing: Participant Characteristics and Early Retention in Community Clinics Samuel A. Ball Kathleen M. Carroll Training Director Principal Investigator Yale University School of Medicine CTN New England Node

“BRIDGING THE GAP” IN THE CLINICAL TRIALS NETWORK (CTN) First CTN psychotherapy protocol to involve front line addiction counselors Goal of effecting and sustaining changes in clinical practice First examination of ‘treatment-as-usual’ Local variation to enhance buy-in Treatment Providers as true partners with Researchers in bidirectional process First randomized clinical trial for all but two of the 11 sites

COMMUNITY TREATMENT PROGRAMS (CTPs) NEW ENGLAND Connecticut Renaissance Liberation Meridian Guenster PACIFIC REGION Haight Ashbury Free Clinic Tarzana Treatment Center NEW YORK Lower East Side Service Center OREGON NODE ChangePoint Willamette Family Treatment Services ADAPT DELAWARE VALLEY Northeast Treatment Center Rehab After Work MID-ATLANTIC NODE Chesterfield County CSB

PROTOCOL DESIGN TEAM Delaware Valley: George Woody Paul Crits-Christoph Thomas McLellan New England:Kathleen Carroll Samuel Ball New York:Jon Morgenstern Pacific Region:Jeanne Obert Douglas Polcin Oregon:Chris Farentinos NIDAIvan Montoya Lisa Onken

TREATMENT – RESEARCH PARTNERSHIP Protocol Development –Local and national survey –Development of two protocols Manual Development Definition of Standard Care for Ratings Therapist Training –Local Experts attend national training –Local Supervisor to enhance sustainability Protocol Implementation

STUDY RATIONALE Attrition is a major issue in substance abuse treatment The bulk of attrition occurs very early in treatment Retention linked to better outcome in several studies

STUDY RATIONALE Brief, motivational approaches have strong empirical support among alcohol & cigarette using populations Effects are clinically significant and durable More data needed on effectiveness in more heterogeneous population of substance abusers and “real world” settings

MOTIVATIONAL INTERVIEWING Principles Express empathy Develop discrepancy Avoid argumentation Roll with resistance Support self-efficacy

MOTIVATIONAL INTERVIEWING Techniques Open-ended questions Affirmation Reflective listening Summary Statements Personal feedback Decision balance Eliciting self-motivational statement Develop alternatives and options

STUDY PRIMARY AIMS To evaluate the efficacy of MI-style assessment, relative to Standard Care assessment in “real world” community treatment programs To evaluate the durability of MI effects and practice relative to standard care through a 3- month follow-up

STUDY DESIGN Multisite randomized clinical trial in five community- based drug treatment programs (CTPs) Single (2-hour) clinical evaluation session comparing Motivational Interviewing (MI) with Standard Care (SC) Clinician characteristics and skill acquisition assessed Treatment fidelity and discriminability monitored Training plan designed to facilitate sustained changes in practice and dissemination

LEVELS OF TRAINING MET/MI Expert Trainer MET/MI Supervisor MET/MI Therapist

EXPERT TRAINER Study site representative(s) who is research investigator/collaborator or trainer Attended two-day “train-the-trainer” meeting in Albuquerque (Drs. Miller and Moyers) Provided training to supervisors and therapists within each clinic performance site Reviewed session audiotapes for supervisory feedback and therapist credentialing Provided face-to-face or phone supervisory meeting with each MI supervisor monthly

SUPERVISOR Preferably clinical or assistant director and higher in clinic hierarchy than the therapists Attended two-day therapist/supervisor training provided by the MI expert trainer Reviewed therapist audiotapes for supervision purposes and consultation with Expert Trainer Meet weekly with therapists (indiv. or group)

THERAPIST No formal MI training in past 3 months or experience providing manualized MI in prior clinical trial Assessed, randomized to MI or Standard Care, trained, audiotaped and supervised to follow treatment manual Completed brief research assessments and pre- and post-protocol tapes Certified by MI expert and supervised by MI supervisor

ADHERENCE & COMPETENCE MONITORING SYSTEM Guided supervision/training process between expert-trainer and supervisor and supervisor and therapist Adaptation of the Yale Adherence & Competence Scale (Carroll et al., 2000) used in several prior clinical trial studies

ADHERENCE & COMPETENCE ITEMS 39 items rated on two 7-point Likert dimensions (frequency/extensiveness and skill level) MI-Consistent sample items: Open-ended Qs Reflections Affirmations Pros/Cons Discrepancies MI Style MI-Inconsistent sample items: Confrontation Skills Training Asserting Authority Psychodynamic Invoking Spirituality Total Abstinence Standard Care sample items: Psychosocial Assess Program Orientation Case Management SA Psychoeducation Assessing Sub. Use Treatment Planning

STUDY PARTICIPANTS Counselors STUDY PARTICIPANTS Counselors (n=32) Predominantly Caucasian (81%), female (66%), with average age of 42.2 Experienced group of clinicians with mean of 7.3 years of counseling experience and mean of 4.1 years working for current agency 56% of sample had masters degrees 66% certified in drug and alcohol counseling or licensed (social work; marriage and family therapy; counseling) 56% of sample self-identified as being in recovery

STUDY PARTICIPANTS Counselor STUDY PARTICIPANTS Counselor Orientation and Techniques Range of common theoretical orientations used for addiction counseling with most frequent being Relapse Prevention/Cognitive-Behavioral (75%) and least frequent being Gestalt/Experiential (9%) When describing their treatment of a typical client seen prior to training, clinicians scored themselves highest on use of motivational interviewing items Relatively few clinicians reported reliance on one dominant theoretical orientation for counseling

STUDY PARTICIPANTS Patients (n=423) Adults seeking outpatient treatment for any type of substance abuse Not seeking or requiring methadone maintenance, detoxification only, or inpatient treatment Sufficiently medically and psychiatrically stable Randomly assigned to MI (n=209) versus Standard Care session (n=214)

STUDY PARTICIPANTS Patient Characteristics Gender 57% Male 43% Female Ethnicity 72% Caucasian 9% African American 4% Hispanic/Latin American 14% Multi-racial Marital 20% Married/cohabitating 33% Separated/Divorced/Widowed 47% Single Age 32.9 Years Education Years

STUDY PARTICIPANTS Patient Characteristics Employment 63% Unemployed Legal 24% Criminal Justice Referred/Mandated 36% No Legal Problems Primary Substance 48% Alcohol 21% Marijuana 19% Methamphetamine 6% Cocaine 5% Opiates 1% Benzodiazepine Past 28 Days Primary Use 9.7 Days

PRIMARY HYPOTHESES During first 28 days of treatment and at a 3-month follow-up, MI > Standard Care session: 1) Retaining patients (proportion still enrolled in treatment at CTP) 2) Decreasing substance use (days of use of primary substance)

PRELIMINARY ANALYSES Effects on Retention Patients assigned to MI subsequently completed more counseling sessions (mean=5.02, sd=5.15) than Standard Care patients (mean=4.03, sd=4.21) during 28 days after randomization (p<.05) MI patients more likely (84%) to still be enrolled at the program after one month than Standard Care patients (75%) (p<.04)

FUTURE ANALYSES Outcomes Primary –Retention in the clinic (attendance) –Days of substance use (SUC, urines, breath) Secondary –Motivation (URICA) –Psychosocial functioning (ASI) –HIV risk behaviors (HRBS) –Treatment utilization (TSR) –Participant satisfaction

FUTURE ANALYSES Matching and Process Evaluate types of participants who respond best to motivational approaches Evaluate the ability of unselected clinicians to implement motivational approaches effectively Evaluate the discriminability of motivational approaches from standard care